Danggui Jixueteng decoction for the treatment of myelosuppression after chemotherapy: A combined metabolomics and network pharmacology analysis

Danggui Jixueteng decoction for the treatment of myelosuppression after chemotherapy: A combined metabolomics and network pharmacology analysis

Objective: This study aimed to explore the mechanism of the Danggui Jixueteng decoction (DJD) in treating Myelosuppression after chemotherapy (MAC) through network pharmacology and metabolomics. Methods: We obtained the chemical structures of DJD compounds from TCMSP and PubMed. SwissTargetPredictio...

Full description

Bibliographic Details
Main Authors: Mingxin Guo, Jiaqi Zeng, Wenjing Li, Zhiqiang Hu, Ying Shen
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Heliyon
Subjects:
Danggui Jixueteng decoction
Myelosuppression after chemotherapy
Network pharmacology
Molecular docking
Hematopoietic microenvironment
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024007266

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024007266

Similar Items